Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Content Filter
Choose a Topic
Agreement
Appointment
Big Data
Biosimilars
Business
Capacity Expansion
CDMO
Cell and Gene Therapy
Clinical Trials
Collaboration
Continuous Manufacturing
CRISPR
CRO
DNA
Drug Delivery
Drug Development
Drug Discovery
Engineering
Equipment
Excipients
Facility
Formulation
Generics
Healthcare
Immunotherapy
Innovation
Investment
Licensing
Logistics
Manufacturing
Market Expansion
Market Intelligence
Market Prediction
Oncology
Oral Solid Dosage
Orphan Drugs
Packaging
Parenterals
Preclinical
Process Development
Regulatory
Research
Serialization
Stem Cells
Strategic Partnership
Supply Chain
Vaccine
Intermediates
×
Choose a Section
Features
News
Press Releases
Roundtable
In Conversation
Nice Consulting
Virtual Panel
Trends Trending
×
Choose an Issue
Issue Q3 2022
Issue Q2 2022
Issue Q1 2022
Issue Q4 2020
Issue Q3 2020
Issue Q2 2020
Issue Q1 2020
Issue Q4 2019
Issue Q3 2019
Issue Q2 2019
Issue Q1 2019
Issue Q4 2018
Issue Q3 2018
Issue Q2 2018
Issue Q1 2018
Issue Q4 2017
Issue Q3 2017
Issue Q2 2017
Issue Q1 2017
Issue Q4 2016
Issue Q3 2016
Issue Q2 2016
Issue Q1 2016
Issue Q4 2015
×
5841 Articles Available
1
244
Can't find what you're looking for? Try our
advanced search
.
Sterile Fill-Finish
PCI Pharma Services Begins Installation of Sterile Fill-Finish and Lyophilization Line as Part of $100 Million New Facility Expansion
PR-M05-24-01
FDA Approval
Possible New Hope for Metastatic Cancer Patients: Food and Drug Administration Grants Approval for Clinical Trials For Lamassu's Groundbreaking Cancer Treatment Protocol
PR-M04-24-01
Down Stream Processing
Expediting Biologics Drug Development: Downstream Strategies to Accelerate Preclinical Development Timelines
PAO-04-24-CL-05
Microfluidics
How Microfluidic Devices are Benefitting Biopharmaceutical Development and Manufacturing
PAO-04-24-NI-02
mRNA Innovations
Technology Advances Needed to Drive Future mRNA Growth
PAO-04-24-CL-04
Cell and Gene Therapy Regulatory
Navigating Regulatory Complexity for Cell and Gene Therapies
mRNA Manufacturing
Navigating mRNA Manufacturing with Flexibility and Innovation
PAO-04-24-CL-02
Nice Insight Reports
Biotech Funding Ups and Downs
PAO-04-24-NI-01
pDNA Manufacturing
Overcoming pDNA Supply Challenges for mRNA Manufacturing
PAO-04-24-CL-01
ESG
Leading CDMO PCI Pharma Services Releases Inaugural Comprehensive ESG Report
PR-M03-24-04
Outsourced Manufacturing
A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing
PAO-03-24-NI-02
IND, NDA, and BLA
Building a Regulatory Roadmap for IND, NDA, and BLA
PAO-03-24-CL-10
Nice Insight API Report
Small Molecule API Discovery and Development Trends
PAO-03-24-NI-01
mRNA–LNP Manufacturing
The Innovators Bringing Continuous Manufacturing to Lipid Nanoparticles
PAO-03-24-CL-08
Radioconjugate development
Expediting Radioimmune Conjugate Pharmaceuticals for First-In-Human Phase 0 Proof-of-Concept Human Studies from Stable Pool
PAO-03-24-CL-07
Lead Share Agreement
List Biotherapeutics and Sacco System Announce Lead Share Agreement
PR-M03-24-03
Viral Vectors
A Viral Vector CDMO Vision that Resonates
PAO-03-24-CL-06
Analytical Method Development
Harnessing Biologic Development Experience in Support of CDMO Clients: Rapid, Effective and Tailored Analytical Method Development
PAO-03-24-CL-09
Biomanufacturing
Antheia and Olon Continue Partnership for Biomanufacturing Antheia’s Pipeline of KSMs and APIs for Essential Medicines
PR-M03-24-02
Clinical Trials Representation
Leveraging Decentralized Clinical Trial Strategies to Reduce Health Care Disparities
PAO-03-24-CL-05
Commitment to ESG Principles
How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?
PAO-03-24-CL-03
Accelerating Product Development
What strategies are being employed to accelerate product development and commercialization without compromising quality?
PAO-03-24-CL-02
Manufacturing Partnership
Genezen Announces Strategic Process Development and Manufacturing Partnership Agreement with Seattle Children’s Research Institute for X-linked Agammaglobulinemia (XLA) Cell Therapy Program
PR-M03-24-01
Clinical Trial Enrollment
NMDP Announces Enrollment of First Patient in OPTIMIZE Clinical Trial
PR-M03-24-01
1
244
»